Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Margaret L. Dahn"'
Autor:
Alamelu G. Bharadwaj, Meghan E. McLean, Margaret L. Dahn, Hannah F. Cahill, Marie‐Claire D. Wasson, Raj Pranap Arun, Olivia L. Walker, Brianne M. Cruickshank, Wasundara Fernando, Jaganathan Venkatesh, Penelope J. Barnes, Gillian Bethune, Gregory Knapp, Lucy K. Helyer, Carman A. Giacomantonio, David M. Waisman, Paola Marcato
Publikováno v:
Molecular Oncology, Vol 18, Iss 1, Pp 91-112 (2024)
Aldehyde dehydrogenase 1A3 (ALDH1A3) is a cancer stem cell marker that promotes metastasis. Triple‐negative breast cancer (TNBC) progression has been linked to ALDH1A3‐induced gene expression changes. To investigate the mechanism of ALDH1A3‐med
Externí odkaz:
https://doaj.org/article/3963ad169532432cb23f181c5b3a6969
Autor:
Mohammad Sultan, Jacob T. Nearing, Justin M. Brown, Thomas T. Huynh, Brianne M. Cruickshank, Emily Lamoureaux, Dejan Vidovic, Margaret L. Dahn, Wasundara Fernando, Krysta M. Coyle, Carman A. Giacomantonio, Morgan G.I. Langille, Paola Marcato
Publikováno v:
Molecular Oncology, Vol 15, Iss 8, Pp 2046-2064 (2021)
Paclitaxel is a common breast cancer drug; however, some tumors are resistant. The identification of biomarkers for paclitaxel resistance or sensitivity would enable the development of strategies to improve treatment efficacy. A genome‐wide in vivo
Externí odkaz:
https://doaj.org/article/b727d6306bc6474fa6e0ff5f6052d777
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss , Pp 398-408 (2021)
Metastasis is the primary cause of cancer-related mortality. Experimental models that accurately reflect changes in metastatic burden are essential tools for developing treatments and to gain a better understanding of disease. Murine xenograft tumor
Externí odkaz:
https://doaj.org/article/41f2ba8c516c455183e0fb59467d33ed
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
Culprits of cancer development, metastasis, and drug resistance, cancer stem cells (CSCs) are characterized by specific markers, active developmental signaling pathways, metabolic plasticity, increased motility, invasiveness, and epithelial-mesenchym
Externí odkaz:
https://doaj.org/article/ea672c930451471e8cc2a6086fc722a4
Autor:
Paola Marcato, Ian C.G. Weaver, Carman A. Giacomantonio, Kerry B. Goralski, David M. Waisman, Hillary Maillet, Krysta M. Coyle, Steven R. Hall, Ryan W. Holloway, Cheryl Dean, Ainsleigh J. Jackson, Brianne M. Cruickshank, Margaret L. Dahn
Microarray gene expression analyses for MDA-MB-468, MDA-MB-231, and SUM159 cells after decitabine treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::665472946697f97513d3da2193889282
https://doi.org/10.1158/1535-7163.22521439
https://doi.org/10.1158/1535-7163.22521439
Autor:
Paola Marcato, Ian C.G. Weaver, Carman A. Giacomantonio, Kerry B. Goralski, David M. Waisman, Hillary Maillet, Krysta M. Coyle, Steven R. Hall, Ryan W. Holloway, Cheryl Dean, Ainsleigh J. Jackson, Brianne M. Cruickshank, Margaret L. Dahn
Gene Set Enrichment Analysis for genes upregulated by decitabine treatment in MDA-MB-468, MDA-MB-231, or SUM159
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::692e93d3cd5ee79e2f56d7879754dd43
https://doi.org/10.1158/1535-7163.22521445
https://doi.org/10.1158/1535-7163.22521445
Autor:
Paola Marcato, Ian C.G. Weaver, Carman A. Giacomantonio, Kerry B. Goralski, David M. Waisman, Hillary Maillet, Krysta M. Coyle, Steven R. Hall, Ryan W. Holloway, Cheryl Dean, Ainsleigh J. Jackson, Brianne M. Cruickshank, Margaret L. Dahn
HM450 DNA methylation B-values for genes up- or down-regulated by decitabine in MDA-MB-468, MDA-MB-231, or SUM159
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8322c2e62101bf8066dce9e13b6508c8
https://doi.org/10.1158/1535-7163.22521442.v1
https://doi.org/10.1158/1535-7163.22521442.v1
Autor:
Paola Marcato, Ian C.G. Weaver, Carman A. Giacomantonio, Kerry B. Goralski, David M. Waisman, Hillary Maillet, Krysta M. Coyle, Steven R. Hall, Ryan W. Holloway, Cheryl Dean, Ainsleigh J. Jackson, Brianne M. Cruickshank, Margaret L. Dahn
Additional figures, tables, and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16ee0ce418e51f19b6dcef9a90694f58
https://doi.org/10.1158/1535-7163.22521436
https://doi.org/10.1158/1535-7163.22521436
Autor:
Paola Marcato, Ian C.G. Weaver, Carman A. Giacomantonio, Kerry B. Goralski, David M. Waisman, Hillary Maillet, Krysta M. Coyle, Steven R. Hall, Ryan W. Holloway, Cheryl Dean, Ainsleigh J. Jackson, Brianne M. Cruickshank, Margaret L. Dahn
Genes up-regulated by decitabine treatment in MDA-MB-468, MDA-MB-231, or SUM159 with hypermethylated promoters (TSS200)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f824b0643fe23b65ae050975a3b15c9
https://doi.org/10.1158/1535-7163.22521433.v1
https://doi.org/10.1158/1535-7163.22521433.v1
Autor:
Krysta M. Coyle, Wasundara Fernando, Emily Lamoureaux, Paola Marcato, Carman A. Giacomantonio, Mohammad Sultan, Brianne M. Cruickshank, Margaret L. Dahn, Justin M Brown, Dejan Vidovic, Morgan G. I. Langille, Jacob T. Nearing, Thomas T. Huynh
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 15, Iss 8, Pp 2046-2064 (2021)
Molecular Oncology, Vol 15, Iss 8, Pp 2046-2064 (2021)
Paclitaxel is a common breast cancer drug; however, some tumors are resistant. The identification of biomarkers for paclitaxel resistance or sensitivity would enable the development of strategies to improve treatment efficacy. A genome‐wide in vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2168987c3059dc2390a7a9928b1fdf8f
http://europepmc.org/articles/PMC8333778
http://europepmc.org/articles/PMC8333778